A new medical device based on a proprietary mixture of natural ingredients for the relief of gastroesophageal reflux symptoms.
Product Background
Gastroesophageal reflux disease (GERD) is a condition in which stomach contents leak backwards from the stomach into the esophagus (the tube from the mouth to the stomach). This can irritate the esophagus and cause heartburn and other symptoms.
Nowadays, GERD is a common condition and its prevalence varies in different parts of the world. Several population-based studies have reported that it is more frequent in Western than in Eastern countries.
GERD is treated via a stepwise approach that is based on lifestyle modifications and control of gastric secretion by means of medical or surgical treatment.
RefluxG® is a medical device that acts locally without systemic absorption via a multiple mechanism of action. It is specially formulated to relieve symptoms of GERD fast.
Key Ingredients
1. Fenugreek Seeds (FenuLife®) – Forms a raft to prevent stomach contents from flowing back up
2. Calcium carbonate & Sodium Carbonate – Neutralises excess stomach acid, reduces hyperacidity and prevents gastric reflux into the oesophagus
3. Malva Sylvestris & Hyaluronic Acid – Provides a protective barrier for the stomach and promotes healing of damaged tissues
> Learn more about RefluxG®
Target
Symptoms associated with:
-
Esophageal reflux (moderate uncomplicated GERD)
-
Reflux esophagitis
-
Acid regurgitation
-
Gastric acidity
-
Heartburn
-
Occasional digestive issues
Benefits & Features
-
Proprietary blend of natural ingredients
-
3-in-1 action: anti-reflux, mucosal barrier, antacid
-
Clinically proven Galactomannan fiber
-
Forms a raft barrier within minutes
-
Alginates & aluminum-free
-
Low sodium formulation
-
Pleasant mild natural flavor
-
Convenient single-dose liquid stick packs
Scientific Evidence
-
Raft-forming capacity evaluation of liquid stick pack medical device (data on file).
-
Anti-heartburn efficacy of fenugreek fiber product (DiSilvestro et al., 2010).
Registered as “Antireflusso (NB 0476)”.
GB6329620-43450
Registered under Act 737
MDAMD 00079/2023
